版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、Respiratory Failure,Dr. Sat SharmaUniv of Manitoba,RESPIRATORY FAILURE,“inability of the lung to meet the metabolic demands of the body. This can be from failure of tissue oxygenation and/or failure of CO2 homeostasis
2、.”,RESPIRATORY FAILURE,Definition Respiration is gas exchange between the organism and its environment. Function of respiratory system is to transfer O2 fr
3、om atmosphere to blood and remove CO2 from blood.Clinically Respiratory failure is defined as PaO2 50 mmHg.,Respiratory system includes:,CNS (medulla)
4、 Peripheral nervous system (phrenic nerve) Respiratory muscles Chest wall
5、 Lung Upper airway Bronchial tree Alveol
6、i Pulmonary vasculature,,Potential causes of Respiratory Failure,HYPOXEMIC RESPIRATORY FAILURE(TYPE 1),PaO2 <60mmHg with normal or low PaCO2 ? normal or hi
7、gh pHMost common form of respiratory failureLung disease is severe to interfere with pulmonary O2 exchange, but over all ventilation is maintainedPhysiologic causes: V/Q mismatch and shunt,HYPOXEMIC RESPIRATO
8、RY FAILURE CAUSES OF ARTERIAL HYPOXEMIA,1.?FiO22.Hypoventilation (? PaCO2) Hypercapnic 3. V/Q mismatch Respiratory failure (eg.COPD)4. Dif
9、fusion limitation ?5. Intrapulmonary shunt - pneumonia - Atelectasis
10、 - CHF (high pressure pulmonary edema) - ARDS (low pressure pulmonary edema),,Causes of Hypoxemic Respiratory
11、 failure,Caused by a disorder of heart, lung or blood. Etiology easier to assess by CXR abnormality:- Normal Chest x-ray Cardiac shunt (right to left) Asthma, C
12、OPD Pulmonary embolism,Hyperinflated Lungs : COPD,Causes of Hypoxemic Respiratory failure (cont’d.),Focal infiltrates on CXR Atelectasis Pneumonia,An example of intrapulmonary shunt,Causes of Hypoxemic Respirat
13、ory Failure (cont’d.),Diffuse infiltrates on CXRCardiogenic Pulmonary EdemaNon cardiogenic pulmonary edema (ARDS)Interstitial pneumonitis or fibrosisInfections,Diffuse pulmonary infiltrates,Hypercapnic Respiratory Fa
14、ilure (Type II),PaCO2 >50 mmHgHypoxemia is always presentpH depends on level of HCO3HCO3 depends on duration of hypercapniaRenal response occurs over days to weeks,Acute Hypercapnic Respiratory Failure (Type II),
15、AcuteArterial pH is lowCauses- sedative drug over dose- acute muscle weakness such as myasthenia gravis- severe lung disease: alveolar ventilation can not be ma
16、intained (i.e. Asthma or pneumonia) Acute on chronic:This occurs in patients with chronic CO2 retention who worsen and have rising CO2 and low pH.Mechanism: respirat
17、ory muscle fatigue,Causes of Hypercapnic Respiratory failure,Respiratory centre (medulla) dysfunctionDrug over dose, CVA, tumor, hypothyroidism,central hypoventilationNeuromuscular disease
18、 Guillain-Barre, Myasthenia Gravis, polio, spinal injuriesChest wall/Pleural diseases kyphoscoliosis, pneumothorax, massive pleural effusionUpper airways obstruction
19、 tumor, foreign body, laryngeal edemaPeripheral airway disorder asthma, COPD,Clinical and Laboratory Manifestation(non-specific and unreliable),Cyanosis
20、 - bluish color of mucous membranes/skin indicate hypoxemia- unoxygenated hemoglobin 50 mg/L - not a sensitive indicator Dyspnea
21、 - secondary to hypercapnia and hypoxemiaParadoxical breathingConfusion, somnolence and comaConvulsions,ASSESSMENT OF PATIENT,Careful historyPhysic
22、al ExaminationABG analysis -classify RF and help with cause 1) PaCO2 = VCO2 x 0.863
23、 VA2) P(A-a)02 = (PiO2 - PaCO2) – PaO2 RLung function
24、 OVP vs RVP vs NVPChest RadiographEKG,Clinical & Laboratory ManifestationsCirculatory changes - tachycardia, hypertension, hypotensionPolycythemia
25、 - chronic hypoxemia - erythropoietin synthesisPulmonary hypertensionCor-pulmonale or right ventricular failure,Management of Respiratory Failure Principles,Hypoxemia may cause
26、death in RFPrimary objective is to reverse and prevent hypoxemiaSecondary objective is to control PaCO2 and respiratory acidosis Treatment of underlying diseasePatient’s CNS and CVS must be monitored and treated,Oxyg
27、en Therapy,Supplemental O2 therapy essential titration based on SaO2, PaO2 levels and PaCO2Goal is to prevent tissue hypoxiaTissue hypoxia occurs (normal Hb & C.O.) - venous PaO2 60 mmHg(SaO2 >
28、90%) or venous SaO2 > 60%O2 dose either flow rate (L/min) or FiO2 (%),Risks of Oxygen Therapy,O2 toxicity: - very high levels(>1000
29、mmHg) CNS toxicity and seizures - lower levels (FiO2 > 60%) and longer exposure: -capillary damage, leak and pulmonary fibrosis
30、 - PaO2 >150 can cause retrolental fibroplasia - FiO2 35 to 40% can be safely tolerated indefinitelyCO2 narcosis:
31、 - PaCO2 may increase severely to cause respiratory acidosis, somnolence and coma - PaCO2 increase secondary to combination of a) aboli
32、tion of hypoxic drive to breathe b) increase in dead space,MECHANICAL VENTILATION,Non invasive with a maskInvasive with an endobronchial tube MV can be volume or pressure cycled
33、 For hypercapnia: - MV increases alveolar ventilation and lowers PaCO2, corrects pH - rests fatigue
34、s respiratory muscles For hypoxemia: - O2 therapy alone does not correct hypoxemia caused by shunt- Most commo
35、n cause of shunt is fluid filled or collapsed alveoli (Pulmonary edema),POSITIVE END EXPIRATORY PRESSURE (PEEP),PEEP increases the end expiratory lung volume (FRC)PEEP recruits collapsed alveoli and prevents recollapse
36、FRC increases, therefore lung becomes more compliantReversal of atelectasis diminishes intrapulmonary shuntExcessive PEEP has adverse effects - decreased cardiac output
37、 - barotrauma (pneumothorax, pneumomediastinum) - increased physiologic dead space - increased work of breathing,PULMONARY
38、EDEMA,Pulmonary edema is an increase in extravascular lung waterInterstitial edema does not impair functionAlveolar edema cause several gas exchange abnormalitiesMovement of fluid is governed by Starling’s equation
39、 QF = KF [(PIV - PIS ) + ? ( ?IS - ?IV )? QF = rate of fluid movement
40、 KF = membrane permeability PIV & PIS are intra vascular and interstitial hydrostatic pressures ?IS and ?IV are interstitial and intravascular oncotic
41、pressures ? reflection coefficientLung edema is cleared by lymphatics,Adult Respiratory distress Syndrome (ARDS),Variety of unrelated massive insults injure gas exchanging surface of LungsFirst described as cli
42、nical syndrome in 1967 by Ashbaugh & Petty Clinical terms synonymous with ARDS Acute respiratory failure Capillary leak syndrome
43、 Da Nang Lung Shock Lung Traumatic wet
44、 Lung Adult hyaline membrane disease,Risk Factors in ARDS,Sepsis 3.8% Cardiopu
45、lmonary bypass 1.7% Transfusion 5.0% Severe pneumonia 12.0% Burn 2
46、.3% Aspiration 35.6% Fracture 5.3% Intravascular coagulopathy 12.5% Two or more of the
47、above 24.6%,PATHOPHYSIOLOGY AND PATHOGENESIS,Diffuse damage to gas-exchanging surface either alveolar or capillary side of membrane Increased vascular permeability causes pulmonary edemaPathology
48、: fluid and RBC in interstitial space, hyaline membranesLoss of surfactant: alveolar collapse,CRITERIA FOR DIAGNOSIS OF ARDS,Clinical history of catastrophic event Pulmonary or Non pulmonary (shock
49、, multi system trauma) Exclude chronic pulmonary diseases
50、 left ventricular failure Must have respiratory distress tachypnea >20 breath/min
51、ute Labored breathing central cyanosis
52、 CXR- diffuse infiltrates PaO2 O.6 Compliance <50 ml/cm H2O increased shunt and
53、dead space,ARDS,MANAGEMENT OF ARDS,Mechanical ventilation corrects hypoxemia/respiratory acidosisFluid management co
54、rrection of anemia and hypovolemiaPharmacological intervention Dopamine to augment C.O. Diuretics
55、 Antibiotics Corticosteroids - no demonstrated benefit early disease, helpful 1 week laterMort
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
評(píng)論
0/150
提交評(píng)論